Items where authors include "Rescigno, P."
Jump to: Article
Number of items: 2.
Article
Rescigno, P., Porta, N., Finneran, L. et al. (26 more authors) (2024) Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial. European Journal of Cancer, 205. 114103. ISSN 0959-8049
Al-janabi, H., Moyes, K., Allen, R. et al. (14 more authors) (2024) Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy. Journal for ImmunoTherapy of Cancer, 12 (7). e009368. ISSN 2051-1426